Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Quantitative Proteomics: A Major Piece in the Precision Medicine Puzzle
Posted on December 22nd, 2017 by Betsy Davis in Pharma R&D
Our genetic make-up, where we live and how we live, are all important factors to consider when we are dealing with disease. For a very long time, medicine has mostly been designed to treat the sickness without much thought to the individual who has it. (more…)
Compound Discovery May Spur Therapies for Autoimmune Conditions
Posted on December 20th, 2017 by Christy J. Wilson in Pharma R&D
People who develop autoimmune often suffer from their effects for the rest of their lives, frustrated by the lack of cure. Though there are various treatments available to help manage some of these conditions, they often don’t work very well and the disease continues to take a major toll on the patient and his or her quality of life. (more…)
How Pharma Can Make the Most of Gene Tech CRISPR
Posted on December 18th, 2017 by Matthew Clark in Pharma R&D
The gene-editing technology CRISPR, which stands for ‘clustered regularly interspaced short palindromic repeats,’ is one of today’s most-talked-about scientific innovations. In just a few years, it’s gone from being a barely known entity to becoming a regular presence in scientific literature. (more…)
Chemists Concerned About How Their Field is Viewed
Posted on December 13th, 2017 by Prima Sung in Chemistry
Chemistry and its importance in everyday life is often underrated at best, and wildly misunderstood at worst. The stock image of scientists in white lab coats holding beakers of toxic chemicals has been hard to shake (more…)
